Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2200058439Phase 4Not yet recruiting
Phase 4, randomised trial of Piminxiao Capsule in chronic idiopathic urticaria (CIU) (2 arms), sponsored by Jiangsu Provincial Hospital of Traditional Chinese Medicine. Primary endpoint: Urticaria Activity Score (UAS). Planned start Apr 2022; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2200058439.